254 related articles for article (PubMed ID: 21119666)
1. Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy.
Vitucci M; Hayes DN; Miller CR
Br J Cancer; 2011 Feb; 104(4):545-53. PubMed ID: 21119666
[TBL] [Abstract][Full Text] [Related]
2. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
3. Molecular and genetic pathways in gliomas: the future of personalized therapeutics.
Grant R; Kolb L; Moliterno J
CNS Oncol; 2014 Mar; 3(2):123-36. PubMed ID: 25055018
[TBL] [Abstract][Full Text] [Related]
4. Clinical ramifications of "genomic staging" of low-grade gliomas.
Verma V; Mehta MP
J Neurooncol; 2016 Sep; 129(2):195-9. PubMed ID: 27401152
[TBL] [Abstract][Full Text] [Related]
5. Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.
Trabelsi S; Chabchoub I; Ksira I; Karmeni N; Mama N; Kanoun S; Burford A; Jury A; Mackay A; Popov S; Bouaouina N; Ben Ahmed S; Mokni M; Tlili K; Krifa H; Yacoubi MT; Jones C; Saad A; H'mida Ben Brahim D
Mol Neurobiol; 2017 May; 54(4):2381-2394. PubMed ID: 26957305
[TBL] [Abstract][Full Text] [Related]
6. [Classification of gliomas. Current progress and perspectives].
Capper D; Reifenberger G
Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
[TBL] [Abstract][Full Text] [Related]
7. [Advance of molecular subtyping and precise treatment for gliomas].
Hua W; Mao Y
Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):63-66. PubMed ID: 28056258
[TBL] [Abstract][Full Text] [Related]
8. Progress on molecular biomarkers and classification of malignant gliomas.
Zhang C; Bao Z; Zhang W; Jiang T
Front Med; 2013 Jun; 7(2):150-6. PubMed ID: 23681890
[TBL] [Abstract][Full Text] [Related]
9. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.
Caskey LS; Fuller GN; Bruner JM; Yung WK; Sawaya RE; Holland EC; Zhang W
Histol Histopathol; 2000 Jul; 15(3):971-81. PubMed ID: 10963139
[TBL] [Abstract][Full Text] [Related]
10. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
[TBL] [Abstract][Full Text] [Related]
11. Integration and analysis of genome-scale data from gliomas.
Riddick G; Fine HA
Nat Rev Neurol; 2011 Jul; 7(8):439-50. PubMed ID: 21727940
[TBL] [Abstract][Full Text] [Related]
12. Primary brain tumours in adults.
Lapointe S; Perry A; Butowski NA
Lancet; 2018 Aug; 392(10145):432-446. PubMed ID: 30060998
[TBL] [Abstract][Full Text] [Related]
13. Gliomas: advances in molecular analysis and characterization.
Boudreau CR; Yang I; Liau LM
Surg Neurol; 2005 Oct; 64(4):286-94; discussion 294. PubMed ID: 16229087
[TBL] [Abstract][Full Text] [Related]
14. Molecular classification of human gliomas using matrix-based comparative genomic hybridization.
Roerig P; Nessling M; Radlwimmer B; Joos S; Wrobel G; Schwaenen C; Reifenberger G; Lichter P
Int J Cancer; 2005 Oct; 117(1):95-103. PubMed ID: 15880582
[TBL] [Abstract][Full Text] [Related]
15. Insights From Molecular Profiling of Adult Glioma.
Diamandis P; Aldape KD
J Clin Oncol; 2017 Jul; 35(21):2386-2393. PubMed ID: 28640696
[TBL] [Abstract][Full Text] [Related]
16. Progress in the application of molecular biomarkers in gliomas.
Wang J; Su HK; Zhao HF; Chen ZP; To SS
Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis to complement histopathological diagnosis of brain tumors.
Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma.
Morokoff A; Ng W; Gogos A; Kaye AH
J Clin Neurosci; 2015 Aug; 22(8):1219-26. PubMed ID: 25957782
[TBL] [Abstract][Full Text] [Related]
19. [Personalized therapy for gliomas].
Wick W; Hau P
Nervenarzt; 2015 Jun; 86(6):692, 694-6, 698-700. PubMed ID: 26022855
[TBL] [Abstract][Full Text] [Related]
20. Molecular Classification of Diffuse Gliomas.
Kalidindi N; Or R; Babak S; Mason W
Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]